Key Statistics
Market Cap$8.62B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$3.67
52W High$191.50
52W Low$86.99
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees925
Price Performance
1 Week+7.77%
3 Month-1.74%
1 Year+56.18%
FinancialsAnnual · QuiverQuant
Revenue$270.60M
Assets$588.24M
Liabilities$397.26M
Net Income$239.24M loss
About
Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze AXSM with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.